Gothenburg, Sweden — Denator AB confirmed today the expansion of the company’s management team through the appointment of Karsten Fjärstedt as Vice President for Global Sales and Marketing.

In his role as vice president, Karsten will provide strategic vision and direction for all sales and marketing activities. Karsten has over 24 years of experience from the biotech and pharmaceutical industry and is joining from GE Healthcare Life Sciences where he has held senior executive management positions over the past 10 years.

I am very excited to join Denator”, Karsten comments, “The company has a unique technology which I think has a great potential of expanding into many different market segments. By strengthening our strategic marketing efforts, we expect to increase the pace of introducing the technology to the wider market place.”

Olof Sköld, CEO at Denator, states: “I am very pleased to announce the appointment of Karsten as VP for Global sales and marketing. With his extensive experience and track record he will significantly strengthen our company.”

Notes to Editors

Enquiries:

Olof Sköld, CEO

Tel: +46 (0)707918335

Email: olof.skold@denator.com

About Denator AB

www.denator.com

Denator AB is a privately held biotech company based in Gothenburg, Sweden. Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling. Stabilization and standardization of sampling processes upstream significantly enhances the quality of data obtained from analytical techniques used downstream. Based upon the company’s proprietary heat inactivation technology platform, Denator is developing solutions that enable scientists to stop sample degradation instantly and so maintain the stability of sample components throughout the analytical workflow.

Stabilizor is a trademark of Denator AB.